Respiratory syncytial virus (RSV) can lead to life-threatening respiratory infections in vulnerable populations including young infants, the elderly and immunocompromised adults. Discover:
- The burden of RSV in high-risk populations
- Unmet needs in RSV and RSV diagnosis
- Strategies for RSV prevention and treatment
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
This content has been developed independently by EPG Health for Medthority and supported by an educational grant from Janssen in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.